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Background:  Individuals with a family history (FH) of coronary heart disease (CHD) possess a higher atherosclerosis burden than those without 
FH. Whether this higher atherosclerosis burden translates to higher rates of adverse clinical events has not been examined. We assessed the 
relationship of coronary artery calcium (CAC) to all-cause mortality among those with and without FH of CHD.
Methods:  This cohort consisted of 44,052 (54±11 years, 54% males) consecutive asymptomatic individuals from 3 sites, free of known CHD, who 
underwent electron beam computed tomography for CAC evaluation for cardiovascular risk assessment. CHD risk factors were prospectively obtained 
by patient interview. The primary endpoint was mortality from any cause.
Results:  16,402 (37%) individuals reported a FH of CHD. Compared to those with no FH of CHD, individuals with a FH were less likely to have 
CAC400 (8% vs. 12%) (p<0.0001). There were 901 deaths (2.1%) over a mean follow-up of 5.6 ± 2.6 years (range 1-13 years). The annualized 
mortality rate was 3.15 deaths per 1,000 person-years (95% confidence interval [CI] 2.90 - 3.42) for those without FH of CHD vs. 4.78 deaths per 
1,000 person-years (95% CI: 4.30-5.31) among study participants reporting a positive FH. Compared to CAC=0, increasing CAC scores (1-99, 100-
399, and >400) were associated with increases in mortality after adjustment for risk factors. Increasing CAC scores were more strongly associated 
with mortality risk among those with a FH (hazard ratio was 2.87-9.86 fold) than those without FH of CHD (1.98-3.80 fold) (interaction<0.05). 
Among 19,898 individuals with CAC=0 at baseline, 13-year all-cause survival was 99.3% and 99.6% for those with and without FH of CHD (p=0.013). 
In multivariate adjusted Cox regression analyses, a FH of CHD was associated with minimally increased risk of all cause mortality (HR 1.53, 95% CI: 
1.00-2,34, p=0.05) in this low risk group (CAC=0).
Conclusion: CAC and FH provide prognostic information beyond traditional risk factors. A higher CAC is associated with a greater risk of mortality 
among those with FH of CHD compared to no FH. In the absence of CAC, FH was marginally associated with higher mortality although the absolute 
rates remain low.
